Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director · president and CEO | September 28, 2026 | September 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date September 28, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 66,418 |
Reported balance
After 2026-09-28 transaction · row 1
1 source rowRow 1 · 2026-09-28 · Sale · Disposed 2,000 · Balance 66,418 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 28, 2026 Filed Sep 30, 2026 22:07 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $513.45 | $1,026,900.00 |
DisclosureSEC source: 0001193125-26-408869 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,418 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| September 18, 2026 Filed Sep 21, 2026 16:24 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $501.40 | $1,002,800.00 |
DisclosureSEC source: 0001193125-26-396365 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,418 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.00 to $502.05. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| August 21, 2026 Filed Aug 24, 2026 13:49 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $541.16 | $1,082,320.00 |
DisclosureSEC source: 0001193125-26-362133 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,418 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.62 to $542.53. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 13:24 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 2,001 | $445.35 Strike: $445.35 | $891,145.35 |
DisclosureSEC source: 0001193125-26-331690 · ownership.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,158 Underlying: Capital Stock · 2,001 shares Expires 2026-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 13:24 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $539.51 | $1,079,020.00 |
DisclosureSEC source: 0001193125-26-331690 · ownership.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,418 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.59 to $543.50. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 13:24 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 19,802 | $529.22 | $10,479,614.44 |
DisclosureSEC source: 0001193125-26-331690 · ownership.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,418 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 13:24 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 2,001 | $445.35 | $891,145.35 |
DisclosureSEC source: 0001193125-26-331690 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2026 Filed May 4, 2026 18:31 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $421.13 | $842,260.00 |
DisclosureSEC source: 0001193125-26-203623 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,219 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $418.99 to $424.95. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| March 27, 2026 Filed Mar 30, 2026 16:42 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 1,500 | $369.37 | $554,055.00 |
DisclosureSEC source: 0001193125-26-131183 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,219 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.76 to $373.24. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 16:11 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $403.18 | $806,360.00 |
DisclosureSEC source: 0001193125-26-105545 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,719 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.31 to $404.68. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Stock Units · Derivative | 5,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,256 Underlying: Capital Stock · 5,114 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 2,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,142 Underlying: Capital Stock · 2,187 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 2,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,329 Underlying: Capital Stock · 2,187 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 1,192 | $469.56 | $559,715.52 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,719 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 0 | $469.56 | $0.00 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 2,714 | $469.56 | $1,274,385.84 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 19:47 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $437.55 | $875,100.00 |
DisclosureSEC source: 0001193125-25-296515 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,197 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $436.13 to $438.53. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 19:48 UTC | CHEMED CORP CHE · Entity 3723 | GrantStock Option (right to buy with tandem tax withholding) · Derivative | 58,672 | $443.79 Strike: $443.79 | $26,038,046.88 |
DisclosureSEC source: 0001193125-25-246713 · ownership.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,159 Underlying: Capital Stock · 58,672 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| September 26, 2025 Filed Sep 29, 2025 15:59 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 3,000 | $461.28 | $1,383,840.00 |
DisclosureSEC source: 0001193125-25-222199 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,197 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $460.03 to $462.44. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| August 05, 2025 Filed Aug 5, 2025 20:42 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $428.55 | $857,100.00 |
DisclosureSEC source: 0000950170-25-103149 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,197 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.08 to $428.96. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporatio, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| May 05, 2025 Filed May 6, 2025 15:59 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 10,000 | $471.74 Strike: $471.74 | $4,717,400.00 |
DisclosureSEC source: 0000950170-25-064122 · ownership.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,487 Underlying: Capital Stock · 10,000 shares Expires 2025-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
| May 05, 2025 Filed May 6, 2025 15:59 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 1,500 | $576.45 | $864,675.00 |
DisclosureSEC source: 0000950170-25-064122 · ownership.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,197 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.98 to $579.54. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4. Read SEC document |
| May 05, 2025 Filed May 6, 2025 15:59 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 8,982 | $574.02 | $5,155,847.64 |
DisclosureSEC source: 0000950170-25-064122 · ownership.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,697 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 05, 2025 Filed May 6, 2025 15:59 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 10,000 | $471.74 | $4,717,400.00 |
DisclosureSEC source: 0000950170-25-064122 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 15:05 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 1,000 | $615.33 | $615,330.00 |
DisclosureSEC source: 0000950170-25-048147 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,679 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $610.33 to $619.45. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 16:03 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $593.67 | $1,187,340.00 |
DisclosureSEC source: 0000950170-25-035218 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,679 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $589.18 to $600.51. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:41 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Stock Units · Derivative | 4,372 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022145 · ownership.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,516 Underlying: Capital Stock · 4,372 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:41 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 2,023 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022145 · ownership.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,144 Underlying: Capital Stock · 2,023 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. F5 · derivative.expiration_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:41 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 2,023 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022145 · ownership.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,167 Underlying: Capital Stock · 2,023 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. F5 · derivative.expiration_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:41 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 2,377 | $553.39 | $1,315,408.03 |
DisclosureSEC source: 0000950170-25-022145 · ownership.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,679 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:41 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 1,235 | $553.39 | $683,436.65 |
DisclosureSEC source: 0000950170-25-022145 · ownership.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2022 through December 31, 2024, compared to a defined peer group of companies. The Company's performance ranked in the 31.3 percentile of that group, yielding an award of 60.4%; including the reinvestment of dividends paid during such period, the award is 61.0% of target. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:41 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 4,086 | $553.39 | $2,261,151.54 |
DisclosureSEC source: 0000950170-25-022145 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performace stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2022 through December 31, 2024. The actual performance of $64.97 exceeded the maximum payout threshold of $63.75 and therefore yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 16:24 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $572.77 | $1,145,540.00 |
DisclosureSEC source: 0000950170-24-130795 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,735 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.93 to $573.89. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each seperate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| October 22, 2024 Filed Oct 23, 2024 18:30 UTC | CHEMED CORP CHE · Entity 3723 | GrantStock Option (right to buy with tandem tax withholding) · Derivative | 40,332 | $597.70 Strike: $597.70 | $24,106,436.40 |
DisclosureSEC source: 0000950170-24-116569 · ownership.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,487 Underlying: Capital Stock · 40,332 shares Expires 2029-10-22 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/22/2025 Read SEC document |
| September 26, 2024 Filed Sep 27, 2024 15:27 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $598.81 | $1,197,620.00 |
DisclosureSEC source: 0000950170-24-109801 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,735 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $597.99 to $600.44. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 05, 2024 Filed Aug 6, 2024 15:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 5,000 | $445.35 Strike: $445.35 | $2,226,750.00 |
DisclosureSEC source: 0000950170-24-091337 · ownership.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,155 Underlying: Capital Stock · 5,000 shares Expires 2026-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022 Read SEC document |
| August 05, 2024 Filed Aug 6, 2024 15:14 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 2,000 | $569.63 | $1,139,260.00 |
DisclosureSEC source: 0000950170-24-091337 · ownership.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,735 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.63 to $579.09. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the numbers of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 05, 2024 Filed Aug 6, 2024 15:14 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 4,314 | $586.14 | $2,528,607.96 |
DisclosureSEC source: 0000950170-24-091337 · ownership.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,735 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| August 05, 2024 Filed Aug 6, 2024 15:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 5,000 | $445.35 | $2,226,750.00 |
DisclosureSEC source: 0000950170-24-091337 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 19:11 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 1,500 | $544.17 | $816,255.00 |
DisclosureSEC source: 0000950170-24-070509 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,049 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $541.94 to $548.00. The reporting person undertakes to provide Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 16, 2024 Filed May 17, 2024 15:05 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 4,000 | $567.54 | $2,270,160.00 |
DisclosureSEC source: 0000950170-24-061381 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,549 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.61 to $568.92. The reporting person undertakes to provide Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 16:28 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Share Units · Derivative | 3,770 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016881 · ownership.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,190 Underlying: Capital Stock · 3,770 shares Expires not disclosed F6 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Chemed Capital Stock. F7 · derivative.exercise_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2024 to December 31, 2026. The determination of the performance level is to be made by March 15, 2027 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2024 to December 31, 2026. The determination of the performance level is to be made by March 15, 2027 and earned shares to be delivered thereafter. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 16:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Share Units · Derivative | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016881 · ownership.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,420 Underlying: Capital Stock · 1,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. F5 · derivative.expiration_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 16:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Share Units · Derivative | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016881 · ownership.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,157 Underlying: Capital Stock · 1,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. F5 · derivative.expiration_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 16:28 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 1,208 | $586.49 | $708,479.92 |
DisclosureSEC source: 0000950170-24-016881 · ownership.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,964 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 16:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 1,623 | $586.49 | $951,873.27 |
DisclosureSEC source: 0000950170-24-016881 · ownership.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2021 through December 31, 2023 compared to a defined peer group of companies. The Company's performance ranked in the 47th percentile of that group, yielding an award of 92.6%; including the reinvestment of dividends paid during such period, the award is 93.4% of target. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 16:28 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 1,081 | $586.49 | $633,995.69 |
DisclosureSEC source: 0000950170-24-016881 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSUs") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2021 through December 31, 2023. The actual performance of 5.47% yielded an award of 61.7% of target; including the reinvestment of dividends paid during such period, the award is 62.2% of target. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 16:56 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 1,500 | $572.77 | $859,155.00 |
DisclosureSEC source: 0001209191-23-058450 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,468 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.13 to $573.87. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| October 31, 2023 Filed Nov 1, 2023 19:37 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 10,000 | $445.35 Strike: $445.35 | $4,453,500.00 |
DisclosureSEC source: 0001209191-23-054007 · doc4.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,155 Underlying: capital stock · 10,000 shares Expires 2026-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022. Read SEC document |
| October 31, 2023 Filed Nov 1, 2023 19:37 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 5,700 | $413.19 Strike: $413.19 | $2,355,183.00 |
DisclosureSEC source: 0001209191-23-054007 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,155 Underlying: capital stock · 5,700 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.